ASILX
Price
$16.38
Change
+$0.01 (+0.06%)
Updated
Dec 3 closing price
Net Assets
1.56B
DHLSX
Price
$31.67
Change
+$0.09 (+0.28%)
Updated
Dec 3 closing price
Net Assets
2.3B
Interact to see
Advertisement

ASILX vs DHLSX

Header iconASILX vs DHLSX Comparison
Open Charts ASILX vs DHLSXBanner chart's image
AB Select US Long/Short I
Price$16.38
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets1.56B
Diamond Hill Long-Short I
Price$31.67
Change+$0.09 (+0.28%)
VolumeN/A
Net Assets2.3B
ASILX vs DHLSX Comparison Chart in %
View a ticker or compare two or three
VS
ASILX vs. DHLSX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASILX is a Buy and DHLSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DHLSX has more cash in the bank: 2.3B vs. ASILX (1.56B). DHLSX pays higher dividends than ASILX: DHLSX (1.97) vs ASILX (0.66). ASILX was incepted earlier than DHLSX: ASILX (13 years) vs DHLSX (21 years). ASILX (1.71) is less costly to investors than DHLSX (1.46). ASILX is a more actively managed with annual turnover of: 296.00 vs. DHLSX (46.00). DHLSX has a lower initial minimum investment than ASILX: DHLSX (2500) vs ASILX (2000000). DHLSX annual gain was more profitable for investors over the last year : 8.36 vs. ASILX (0.76). DHLSX return over 5 years is better than : 25.00 vs. ASILX (17.71).
ASILXDHLSXASILX / DHLSX
Total Expense Ratio1.671.46114%
Annual Report Gross Expense Ratio1.711.46117%
Fund Existence13 years21 years-
Gain YTD9.36516.36057%
Front LoadN/AN/A-
Min. Initial Investment2000000250080,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B2.3B68%
Annual Yield % from dividends0.661.9733%
Returns for 1 year0.768.369%
Returns for 3 years23.8125.0895%
Returns for 5 years17.7125.0071%
Returns for 10 years40.2438.65104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWPHF9.36N/A
N/A
Newron Pharmaceuticals SPA
EQTL1.25N/A
N/A
Equitech Int'l Corp.
MBGPF0.92N/A
N/A
MOBERG PHARMA AB
ANIOY6.94N/A
N/A
Acerinox S.A.
ASCCF23.60N/A
N/A
Asics Corp.